Topline data were announced from a phase 3 trial evaluating secukinumab in patients with polymyalgia rheumatica.

The latest figures from the DWP show there are now nearly 1.2 million adults across the UK receiving support through PIP for ...

The DWP has released the latest figures, revealing that nearly 1.2 million adults across Great Britain are now receiving ...

If your ability to work is limited due to your symptoms, you could qualify for 'new style' Employment and Support Allowance ...

Novartis' Cosentyx Phase 3 REPLENISH trial for polymyalgia rheumatica met primary and secondary endpoints, showing ...

Novartis said that its immunology drug Cosentyx met the primary target and all secondary ones in a late-stage trial for the treatment of patients with inflammatory disease polymyalgia rheumatica.

A logical approach to investigating a case of muscle ‘aches and pains’ to rule out serious pathology and reach a diagnosis ...

Sparrow Pharmaceuticals is looking to send its potential diabetes treatment soaring through clinical trials with the help of a $95 million series B, the company announced in a Sept. 24 release. The ...

In Phase III studies, Tonmya showed significantly superior analgesic effects in patients with fibromyalgia versus placebo. The sublingual pill also led to better clinical outcomes. After more than a ...

Tonix Pharmaceuticals was founded in 2010 to develop and bring to market a drug for fibromyalgia. Fifteen years later, the New Jersey company has accomplished its mission with the FDA's endorsement of ...

In a long-term follow-up study, patients with isolated polymyalgia rheumatica (PMR) and biopsy-confirmed giant cell arteritis (GCA) had no increased all-cause mortality compared with matched ...

In patients with relapsing polymyalgia rheumatica, sarilumab with a rapid glucocorticoid taper regimen of 14 weeks led to greater improvements in patient-reported outcomes of health-related quality of ...